USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
14.34
-1.13 (-7.30%)
At close: Aug 10, 2026, 4:00 PM EDT
14.48
+0.14 (0.98%)
After-hours: Aug 10, 2026, 7:46 PM EDT

USANA Health Sciences Financials Overview

Millions USD. Fiscal year is Feb - Jan.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Revenue
913.36925.26854.5921.01998.61,186
Revenue Growth
1.57%8.28%-7.22%-7.77%-15.83%4.57%
Gross Profit
707.36724.41693.29744.32804.71968.57
Operating Income
-1.0837.4366.3293.07107.61170.19
Net Income
-22.1610.7642.0363.7969.35116.51
Earnings Per Share
-1.210.582.193.303.595.73
EPS Growth
--73.52%-33.64%-8.08%-37.35%-2.22%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Core nutritional
761.5775.45845.79915.21995.041,186
Hiya
121.36131.971.97---
Other
-17.836.745.83.56-
Total
913.36925.26854.5921.01998.61,186

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Investments
168.56158.38181.77330.42288.42239.83
Total Debt
014230.7900
Net Cash (Debt)
168.56144.38158.77329.63288.42239.83
Net Cash Growth
11.38%-9.06%-51.84%14.29%20.26%-23.11%
Net Cash Per Share
9.177.778.2917.0414.9411.79

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingApr '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Operating Cash Flow
16.6322.3560.9970.64103.9121.23
Capital Expenditures
-13.67-13.82-10.07-14.49-10.4-12.76
Free Cash Flow
2.968.5350.9256.1593.5108.46
Free Cash Flow Growth
-93.97%-83.26%-9.31%-39.95%-13.79%-25.36%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Gross Margin
77.45%78.29%81.13%80.82%80.58%81.63%
Operating Margin
-0.12%4.05%7.76%10.11%10.78%14.34%
Pretax Margin
0.28%4.49%8.94%11.12%10.88%14.38%
Profit Margin
-3.20%1.24%4.92%6.93%6.94%9.82%
FCF Margin
0.00%0.92%5.96%6.10%9.36%9.14%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
PE Ratio
-33.5216.3016.2414.8217.66
Forward PE
14.0611.1714.3119.8517.0519.17
P/FCF Ratio
89.4241.6813.3618.2610.9318.09
PS Ratio
0.290.380.801.111.021.65